雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Hyperbradykininemina in Generalized Anxiety Disorder Katsuhiko FUKUDA 1 , Yoshiatsu TAKAHASHI 1 , Gaku YAMANAKA 1 , Yoshihiko WATANABE 1 , Shin-ichiro OHKAWA 1 1Department of Medicine, Tokyo Women's Medical University Daini Hospital Keyword: Bradykinin , Hamilton Anxiety Rating Scale , Generalized anxiety disorder pp.63-68
Published Date 2002/1/15
DOI https://doi.org/10.11477/mf.1405902566
  • Abstract
  • Look Inside

Objective: Hyperbradykininemia was reported in case of angioedema and dry cough as an adverse effect of angiotensin-converting-enzyme (ACE) inhibitors. There is a possibility that the choking sensation, shortness of breath, or smothering sensation in anxiety neurosis could he induced by bradykinin (BK). We sought to examine plasma-BK concentrations of Generalized Anxiety Disorder (GAD) and postulated a new concept of anxiety disorders.

Method: We identified 11 GAD patients. We measured inflammatory markers (WBC, ESR, CRP). Cl-inhibitor activity and circulating BK using a newly developed radioimmunoassay technique. Anxiety was measured using the Hamilton Anxiety Rating Scale (HAM-A).

Results: No abnormalities were found in WBC, ESR, CRP and Cl-inhibitor activity. There were substantial rises in BK in GAD with a mean plasma-BK concentration of 100.1 pg/ml (SD=44.6). There was a significant correlation between HAM-A and plasma-BK concentration in the 11 GAD patients, expressed by the regression: BK=5.10 (HAM-A) -51.5, r=0.62, p<0.05. There was no significant correlation between Cl-inhibitor activity and plasma-BK concentration.

Discussion: The fact that there was no-significant correlation between Cl-inhibitor activity and plasma-BK concentration demonstrates the difference from laryngeal edema in patients with hereditary angioedema. The symptoms of anxiety could be explained by the nature of BK which acts to produce pain, vasodilation, increased vascular permeability, and synthesis of prostaglandins. Therefore, GAD may be termed a diffuse nociceptive state, or an incomplete inflammatory state tmcoupling from other inflammatory markers.


Copyright © 2002, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-126X 印刷版ISSN 0488-1281 医学書院

関連文献

もっと見る

文献を共有